The development of biologics to target SARS-CoV2: Treatment potential of antibodies in patient groups with poor immune response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The development of biologics to target SARS-CoV2: Treatment potential of antibodies in patient groups with poor immune response

Published:2021 Issue: Volume:2 Page:100064
ISSN:2590-2571
Container-title:Current Research in Pharmacology and Drug Discovery
language:en
Short-container-title:Current Research in Pharmacology and Drug Discovery

Author:

Migo William,Boskovic Marko,Likic Robert

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort;Albiges;Nature News,2020

2. March). COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients;Belsky;J. Infect.,2021

3. Immunogenicity of a Single Dose of SARS-CoV-2 mRNA Vaccine in Solid Organ Transplant Recipients;Boyarsky,2021

4. Altering the Genome by Homologous Recombination;Capecchi,1989

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A human monoclonal antibody neutralizes SARS-CoV-2 Omicron variants by targeting the upstream region of spike protein HR2 motif;hLife;2024-03

2. Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinations;Current Opinion in Neurology;2022-06

3. Convalescent Plasma Therapy, Therapeutic Formulations of Repurposed Drugs in 20th Century Epidemics against COVID-19: A Systematic Review;Pharmaceutics;2022-05-09

4. COVID-19 therapy, from lung disease to systemic disorder;Current Research in Pharmacology and Drug Discovery;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3